Rosetta Genomics, Ltd. (NASDAQ: ROSG) reports Q4 non-GAAP loss of $0.29. Revenue for the quarter was $806K, versus ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE